Search

everythinglearnresearchcommunity

for

Search:↓

Docetaxel treatment for breast cancer can cause permanent hair loss.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Spironolactone does not increase the risk of breast cancer recurrence.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

WNT10B is linked to cancer development and affects survival and disease progression in various cancers.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Antidepressants called SSRIs can cause skin problems, bleeding risk, and other side effects.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Oral contraceptives provide various health benefits beyond birth control, including managing menstrual issues, skin conditions, pain, and reducing the risk of certain cancers.

More research needed to confirm finasteride as standard treatment for FFA.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.